FDA Drug Review Head Is Jenkins, Ending 15-Month Search
This article was originally published in The Tan Sheet
Executive Summary
Office of Drug Evaluation II Director John Jenkins, MD, will take over as FDA's top drug review manager effective Jan. 2. The agency announced the appointment of Jenkins as Office of Review Management director in a staff memo Dec. 11